This article is brought to you by the new Higher Learning LV Cannabis for Cancer seminar. At only $80, this affordable online seminar teaches students the nuanced biochemistry of cannabis in the treatment of cancer by citing and summarizing the latest peer-reviewed scientific studies.
Cannabis for Cancer Patients Survey. A 2022 study entitled "Cannabis in Cancer Survivors Who Report High Impact Chronic Pain: Findings from a 1500+ Patient Survey" that was published in the American Journal of Hospice and Palliative Medicine explored how cannabis medicine might assist cancer survivors who endure chronic pain.
"This study sought to investigate the relationship between high-impact chronic pain (HICP)—defined as chronic pain that limits life or work activities on most days or every day in the past 3 months—and cannabis in cancer survivors," reported the scientists.
"This study sought to investigate the relationship between high-impact chronic pain (HICP)—defined as chronic pain that limits life or work activities on most days or every day in the past 3 months—and cannabis in cancer survivors."
The research noted that chronic pain in cancer survivors "negatively impacts quality of life." The study was administered in the form of an online survey developed with the National Cancer Institute Comprehensive Cancer Centers in the United States. "This survey was distributed to cancer survivors within a multi-site, single institution setting," reported the study.
Cannabis for Cancer Patient Survey Results
Cannabis for Cancer Patients Survey. Of the survey respondents, 1,676 had a confirmed cancer diagnosis. Of these, 12.4 percent reported using cannabis since their cancer diagnosis. The study found that cancer survivors with pain were more likely to "believe in the benefits of cannabis and less likely to believe in its risks."
"Cancer survivors with [chronic pain] have a higher prevalence of cannabis use compared to those patients without pain," reported the scientists.
"Cancer survivors with [chronic pain] have a higher prevalence of cannabis use compared to those patients without pain," reported the scientists. However, they cautioned that "more research is needed to advance pain and symptom management among cancer survivors and to identify clinical scenarios in which benefit is greater than potential harm."
View the original study.
Did you enjoy Cannabis for Cancer Patients Survey? Are you a cannabis industry professional? Check out Higher Learning LV's Deep Dive Subscription that features dozens of long-form articles based on the latest peer-reviewed scientific research. Priced to accommodate personal and enterprise training budgets.